Ramipril Capsule
Product Images NDC 71335-1056

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 71335-1056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351056)

Ramipril 2.5 mg capsule label by Bryant Ranch Prepack. The label notes comparison to Altace 2.5 mg capsule from Aurobindo Pharma Limited. Packaging indicates 30 capsules, with a storage temperature range of 20°-25°C (68°-77°F). It includes warnings to keep drugs out of reach of children and shows an NDC of 71335-1056-1 as well as a barcode and lot number.*

FDA Label Image

Figure 1 (Ramipril Fig1)

A line graph comparing the proportion of patients over days of follow-up between Ramipril and placebo groups. The x-axis represents days of follow-up up to approximately 1600 days, and the y-axis shows the proportion of patients up to 0.20. Two lines are plotted: a solid line for Ramipril and a dashed line for placebo, with the placebo group showing a higher proportion of patients over time. A p-value of 0.0001 is noted on the graph.*

FDA Label Image

Figure 2 (Ramipril Fig2)

A forest plot chart showing the relative risk in the Ramipril group with 95% confidence intervals across various patient subgroups, including cardiovascular disease, diabetes, age, sex, hypertension, coronary artery disease history, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The chart compares incidence of composite outcomes between Ramipril and placebo groups, displaying the number of patients and corresponding risk estimates.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure diagram of ramipril, showing its molecular bonds and groups including a cyclopentane ring and carboxyl group, consistent with the active ingredient ramipril.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.